Sustaining growth in difficult times
      The fourth wave of the Covid-19 pandemic has caused many businesses to struggle, and pharmaceutical enterprises are no exception. However, amidst these challenges, Danapha has demonstrated the ability to adapt quickly and create "antibodies" on its own and even a spectacular breakthrough in production and business activities, and positive contributions to the community and society
       In 2021, the Company had planned that net revenue is expected to reach VND 445 billion, 13.9% higher than the result achieved in 2020; profit after tax is VND 52.8 billion, 1.7 times higher than the result of 2020. Danapha's business result in the first 9 months of 2021 is quite positive with net revenue of nearly VND 327 billion, an increase of 14.5% over the same period last year. Profit after tax reached VND 43.1 billion, 2.3 times higher than the same period in 2020. By the end of the third quarter of 2021, Danapha's total assets reached VND 863.6 billion.
       Notably, in October 2021, Danapha commenced the construction of the first "High tech Pharmaceutical factory and Research & development center" in Da Nang Hi-Tech Park. Besides, more than 21 million shares of Danapha (DAN) were offered on the floor, the reference price of DAN stock on the first trading day was 32,000 VND/share and Danapha also "set a record" with $7.4 million export sales - the highest export sales that Danapha has achieved during the business's operation up to this point.

Danapha Pharmaceuticals has a spectacular growth in 2021

Join hands for the community
       Well aware of the role of enterprises in the prevention of Covid-19, Danapha has supported the Covid-19 COVID-19 prevention and control fund of Da Nang City, donated goods to support the People of the Russian Federation in the fight against Covid-19, presented a set of online meeting equipment and goods for Covid-19 prevention to the Department of Health of Da Nang City; Danapha is also a unit that actively participates in social activities of charity, gratitude, and support for children suffering from serious diseases through activities such as: nurturing Vietnamese heroic mothers, giving gifts to the Children with cancer at Da Nang Oncology Hospital, regularly visit and support employees who are in difficult circumstances or have relatives with serious diseases... with an amount of up to 700 million VND.
      Danapha's active activities over the past time not only have practical meaning to join hands to fight against the Covid-19 epidemic and spread love, but also show Danapha's sense of responsibility for the community.

Danapha Pharmacy brings "Christmas love" to pediatric patient

Constantly improving value
       Proof of the efforts that Danapha has achieved are noble awards such as: National Brand, Top 100 Sustainable Enterprises, Golden Products for Health, Enterprises with excellent fulfillment of tax obligations, Prestigious Exporting Enterprise...for many years.

Danapha Pharmaceutical was honored at the "Vietnam Value" award ceremony

       In addition to continuously investing in modern manufacturing plants, meeting high quality standards, the human factor is also Danapha's top concern. Danapha has created a professional, friendly and safe working environment to ensure the best working conditions for employees, typically: arranging well-organized "3-on-the-spot" activities during the outbreak epidemic period, building a modern industrial kitchen right at the company's premises..., increasing personnel recruitment, Danapha's employee income increased by 16% compared to 2020.
       Overcoming the difficulties of a year affected by the Covid-19 epidemic, Danapha still maintains its pioneering position in the pharmaceutical industry. Many activities of the company are still on schedule, in the near future High-tech pharmaceutical factory will be put into operation to meet the increasing demand in community health care.
       Welcoming a new year, Danapha will remain steadfast on the path of sustainable development, while proactively responding and promptly adapting to all challenges, contributing to enhancing corporate value to further affirm its leading pioneering position and bringing the company's products to become the leading brand in the field of pharmaceutical production in the country as well as in the international market